Susan Dorman
Faculty Director, Center for Global Health · Medical University of South Carolina College of Medicine
Credentials: · · · ·
History
PresentCenter for Global Health · Medical University of South Carolina College of Medicine
- 1996–1998
Infectious Disease
1989–1993- 1985–1989
Trinity College
Research
Clinical Infectious Diseases · 2016 · 908 citations
The Lancet Infectious Diseases · 2018 · First of 33 authors · 549 citations
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
New England Journal of Medicine · 2021 · First of 33 authors · 409 citations
33 papers
29 papers · 3 as a fellow
26 papers
22 papers
22 papers
19 papers · 1 as a fellow
- SH
16 papers
15 papers
Grants
- 2025–2030
National Institute of Allergy and Infectious Diseases · R01
PI · $6.2M · Rutgers Biomedical and Health Sciences
- 2025–2030
CTSA K12 Program at the Medical University of South Carolina
National Center for Advancing Translational Sciences · K12
PI · $756K · Medical University of South Carolina
- 2025–2027
Novel Strategies for Treatment of Mycobacterium Abscessus Pulmonary Disease
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $240.9K · Medical University of South Carolina
- 2020–2026
National Institute of Allergy and Infectious Diseases · U01
PI · $19.8M · Rutgers Biomedical and Health Sciences
Clinical trials
- 2010–2011
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers
Principal investigator · Completed · Phase 1
Johns Hopkins University
- 2010–2014
Study of Daily Rifapentine for Pulmonary Tuberculosis
Principal investigator · Completed · Phase 2
Johns Hopkins University
- 2009–2013
Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
Principal investigator · Terminated · Phase 2
Johns Hopkins University
- 2008–2013
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Principal investigator · Completed · Phase 2
Centers for Disease Control and Prevention